TransMedics Group, Inc. (TMDX) · Insider Trading (Form 4) SEC Filing

=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-05-19 10b5-1 Pre-arranged Plan: No --- Issuer --- Name: TransMedics Group, Inc. (TMDX) CIK: 0001756262 --- Reporting Owner --- Name: Forsyth Matthew S. CIK: 0002120002 Role: Officer (See Remarks) --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-05-19 | Code: A (Grant or award) Shares: +15,409 | Price: $0.00 Shares Owned After: 15,409 | Ownership: D (Direct) Footnotes: [F1] Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. --- Derivative Transactions --- [Transaction #1] Security: Stock Option (Right to Buy) Date: 2026-05-19 | Code: A (Grant or award) Shares: +23,171 | Price: $0.00 Exercisable: N/A | Expires: 2036-03-09 Shares Owned After: 23,171 | Ownership: D (Direct) Footnotes: [F2] The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. --- Footnotes (Complete Index) --- F1: Consists of 15,409 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: The option vests as to 25% of the shares underlying the option on March 9, 2027 and as to the remaining shares in equal monthly installments over three years thereafter, subject to continued service. --- Signature --- /s/ By: /s/ Gerardo Hernandez, Attorney-in-Fact (2026-05-21)